Bicycle Therapeutics Long Term Deferred Assets (Quarterly) Insights

Bicycle Therapeutics Plc (BCYC)

6.51 +0.04 (+0.62%) USD | NASDAQ | Jan 16, 16:00

6.50 -0.01 (-0.15%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for BCYC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Biodexa Pharmaceuticals Plc	--
NuCana Plc	Upgrade
Mereo BioPharma Group Plc	--
Autolus Therapeutics Plc	Upgrade
DBV Technologies SA	--